CLEO DIAGNOSTICS LIMITED (COV)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

COV - CLEO DIAGNOSTICS LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.36

26 Dec
2024

0.000

OPEN

$0.36

0.000

HIGH

$0.36

0

LOW

$0.36

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 20232024
EPS Basic xxx-3.2
DPS All xxx0.0
Sales/Revenue xxx0.0 M
Book Value Per Share xxx7.3
Net Operating Cash Flow xxx-2.0 M
Net Profit Margin xxx-

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20232024
Return on Capital Employed xxx-88.99 %
Return on Invested Capital xxx-88.99 %
Return on Assets xxx-68.63 %
Return on Equity xxx-88.99 %
Return on Total Capital xxx-86.24 %
Free Cash Flow ex dividends xxx-2.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20232024
Short-Term Debt xxx0 M
Long Term Debt xxx0 M
Total Debt xxx0 M
Goodwill - Gross xxx-
Cash & Equivalents - Generic xxx9 M
Price To Book Value xxx4.65

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20232024
Capex xxx0.0 M
Capex % of Sales xxx-
Cost of Goods Sold xxx0 M
Selling, General & Admin. Exp & Other xxx4 M
Research & Development xxx3 M
Investments - Total xxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

COV STOCK CHART

FNArena News on COV